You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,348,216


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,348,216
Title: Ibuprofen and narcotic analgesic compositions
Abstract:Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising ibuprofen; a narcotic analgesic; colloidal silicon dioxide; a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate; a binder consisting of an akylhydroxy methylcellulose; a starch; and a lubricant. Also provided herein is a method of preparing a pharmaceutical tablet composition comprising: (a) Granulating ibuprofen, a narcotic analgesic, a first glidant, a first disintegrant, a binder, and starch to form granules wherein said granulating step comprises a wet granulation process; (b) blending the granules with extra-granular material comprised of a second glidant, a second disintegrant, a filler and starch to form a blend of granules and extra-granular material; and (c) compressing the blend into a tablet.
Inventor(s): Kushla; Gregory P. (Florham Park, NJ), Lai; Jin-Wang (Edison, NJ), Polli; Gerald P. (Valley Forge, PA)
Assignee: Knoll Pharmaceutical Company (Mt. Olive, NJ)
Application Number:08/872,216
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,348,216

To delve into the specifics of the United States Patent 6,348,216, it is crucial to analyze several key aspects, including the patent's background, its claims, the technological context, and the broader patent landscape.

Patent Background

United States Patent 6,348,216, like many patents, is part of a larger family of patents that may include continuations, continuations-in-part, and divisions. Understanding the patent's family and its relationships with other patents is essential for a comprehensive analysis.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. The claims of U.S. Patent 6,348,216 would typically be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[5].

Claim Types

  • Independent Claims: These claims define the broadest scope of the invention and are not dependent on any other claims.
  • Dependent Claims: These claims narrow down the invention by adding additional limitations to the independent claims.

Claim Interpretation

The interpretation of patent claims is critical for understanding the patent's scope. Claims must be read in light of the specification and the prosecution history of the patent. This ensures that the claims are not overly broad and that they accurately reflect the invention described in the patent[5].

Technological Context

Technology Area

The patent would be classified under a specific technology area based on the World Intellectual Property Organization (WIPO) classification system. For example, if the patent pertains to electrical engineering, it would fall under one of the five subclasses within the electrical engineering technology area[4].

Trends in Patenting

Analyzing the trends in the relevant technology area can provide insights into the patent's significance and its place within the broader innovation landscape. For instance, if the patent is in a field like electrical engineering, it would be part of a sector that has seen significant growth, particularly in areas like computer technology and digital communication[4].

Patent Landscape

Competitors and Related Patents

Understanding the patent landscape involves identifying other patents and patent applications in the same or related fields. This includes analyzing patents held by competitors and determining how they intersect or differentiate from U.S. Patent 6,348,216.

Patent Family

The patent family includes all related patents, such as continuations, continuations-in-part, and divisions. For example, if U.S. Patent 6,348,216 is a continuation-in-part of another patent, it would share a common specification but could introduce new subject matter[1].

Patent Term Adjustment (PTA)

Patents may receive Patent Term Adjustment (PTA) for delays during prosecution, which can extend the patent term. Understanding any PTA granted to U.S. Patent 6,348,216 and its family members is crucial for determining the actual expiration dates of these patents[1].

Legal Considerations

Obviousness-Type Double Patenting (ODP)

Patents within the same family can be subject to obviousness-type double patenting (ODP) analysis. This ensures that multiple patents do not claim the same invention or obvious variations thereof[1].

Reissue and Continuation Applications

If there are reissue or continuation applications related to U.S. Patent 6,348,216, they must comply with specific statutory requirements. For reissue claims, they must be directed to the invention disclosed in the original patent, as per 35 U.S.C. ยง 251[5].

Economic and Innovation Impact

Patent Activity Trends

The number of patents granted in the relevant technology area can indicate the level of innovation and competition. For instance, in 2018, electrical and mechanical engineering patents made up about 60% of all USPTO-granted patents, highlighting the vibrant innovation in these fields[4].

Data Analysis

Utilizing datasets such as the Patent Claims Research Dataset provided by the USPTO can offer detailed insights into patent scope and trends. This dataset includes claim-level statistics and document-level statistics, which can be used to analyze the breadth and depth of U.S. Patent 6,348,216 and its family members[3].

Stakeholder Input and Policy Considerations

Small Claims Patent Court

The discussion around establishing a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), highlights the need for more accessible and efficient patent dispute resolution mechanisms. This could impact how patents like U.S. Patent 6,348,216 are enforced and litigated[2].

Key Takeaways

  • Claims Analysis: Understanding the structure and interpretation of patent claims is crucial for defining the scope of the invention.
  • Technological Context: The patent's classification and trends in the relevant technology area provide insights into its significance and innovation impact.
  • Patent Landscape: Analyzing the patent family, competitors, and related patents helps in understanding the patent's position within the broader landscape.
  • Legal Considerations: Compliance with statutory requirements such as ODP and reissue claims is essential.
  • Economic and Innovation Impact: The patent's contribution to innovation trends and its economic impact can be assessed through patent activity data and datasets.

FAQs

What is the significance of the patent family in analyzing U.S. Patent 6,348,216?

The patent family includes all related patents, such as continuations, continuations-in-part, and divisions, which helps in understanding the full scope and relationships of the inventions.

How does the Patent Term Adjustment (PTA) affect the expiration date of U.S. Patent 6,348,216?

PTA can extend the patent term due to delays during prosecution, which means the actual expiration date may be later than the initial expiration date calculated from the grant date.

What is obviousness-type double patenting (ODP), and how does it apply to U.S. Patent 6,348,216?

ODP analysis ensures that multiple patents within the same family do not claim the same invention or obvious variations thereof, preventing the extension of patent term through multiple patents.

How can the Patent Claims Research Dataset help in analyzing U.S. Patent 6,348,216?

The dataset provides detailed information on claims, including claim-level statistics and document-level statistics, which can be used to analyze the breadth and depth of the patent and its family members.

What are the implications of a small claims patent court on the enforcement of U.S. Patent 6,348,216?

A small claims patent court could provide a more accessible and efficient mechanism for resolving patent disputes, potentially affecting how patents like U.S. Patent 6,348,216 are enforced and litigated.

Cited Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Claims Research Dataset, United States Patent and Trademark Office.
  4. Invention: U.S. and Comparative Global Trends, National Science Foundation.
  5. In Re FLOAT'N'GRILL LLC, United States Court of Appeals for the Federal Circuit, July 12, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,348,216

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.